EAM Global Investors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-70,872
Closed -$4.84M 127
2023
Q2
$4.84M Buy
70,872
+7,752
+12% +$500K 1.42% 14
2023
Q1
$3.06M Sell
63,120
-13,533
-18% -$715K 0.86% 77
2022
Q4
$4.62M Hold
76,653
1.19% 11
2022
Q3
$4.65M Buy
+76,653
New +$2.42M 1.24% 10
2021
Q4
Sell
-49,720
Closed -$3.54M 248
2021
Q3
$3.54M Sell
49,720
-20,535
-29% -$1.28M 0.84% 23
2021
Q2
$3.61M Sell
70,255
-16,605
-19% -$518K 1% 15
2021
Q1
$2.18M Buy
+86,860
New +$1.63M 0.6% 96

Other funds holding PRTA

EAM Global Investors's PRTA Position: Q3 2023 in Review

EAM Global Investors sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 70,872 shares — an estimated $4.84M sold.

EAM Global Investors first reported a position in PRTA in Q1 2021 and held it in 7 quarters. The position peaked at $4.84M in Q2 2023. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

  • EAM Global Investors reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
  • EAM Global Investors sold 70,872 Prothena Corp shares in Q3 2023, an estimated $4.84M.
  • EAM Global Investors first reported a position in Prothena Corp in Q1 2021 and held it in 7 quarters.
  • EAM Global Investors's Prothena Corp position peaked at $4.84M in Q2 2023.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on EAM Global Investors's 13F filing for Q3 2023, filed 13 Nov 2023.